Arrow Electronics, Inc. provides products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Global Components and Global Enterprise Computing Solutions. The Global Components segment markets and distributes electronic components comprising semiconductor products and related services; interconnect, passive, and electromechanical products, including capacitors, resistors, potentiometers, power supplies, relays, switches, and connectors; and computing and memory products, as well as other products and services. The Global Enterprise Computing Solutions segment offers computing solutions, such as datacenter, cloud, security, and analytics solutions. This segment also provides access to various services, including engineering and integration support, warehousing and logistics, marketing resources, and authorized hardware and software training. It serves original equipment manufacturers, value-added resellers, managed service providers, contract manufacturers, and other commercial customers. The company was founded in 1935 and is based in Centennial, Colorado.

Arrow Electronics Inc.

Wells Fargo analyst Joseph Quatrochi maintained a Sell rating on Arrow Electronics on January 23 and set a price target of $94.00. The company’s sh...

Wells Fargo Reaffirms Their Sell Rating on Arrow Electronics (ARW)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Belite Bio, Inc. ADR (BLTE – Research Report), Arrow...

Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arrowhead Pharmaceuticals (ARWR) and Alector (ALEC)

Arrowhead Pharmaceuticals, Inc. ($ARWR) announced an update on their ongoing clinical study. Study Overview This Phase 1/2a study, officially title...

Arrowhead’s ARO-DIMERPA Trial Advances in Mixed Hyperlipidemia: What Investors Should Watch

In a report released today, from Goldman Sachs maintained a Hold rating on Arrowhead Pharmaceuticals, with a price target of $85.00. In addition to...

Current Quarter	$3.55	Next Quarter	$2.3
Current Year	$10.19	Next Year	$11.9
QoQ Growth	-35.2%	YoY Growth	+16.8%
3Y EPS CAGR	-21.6%	Target Price	$108.25
Consensus	Buy	Upside	-19.0%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ARW	$133.62	+0.85%	676.91K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ARW	$133.62	+0.9%	676.91K
3
4
5
6

ARW

ARW

EPS Estimates Overview

EPS Historical Trend (5 Years)

Quarterly EPS Estimates

Revenue Analysis

Get Arrow Electronics Inc. Data in Excel

Get Arrow Electronics Inc. Data in Excel